HtrA Serine Peptidase 4 (HTRA4) (Middle Region) Peptid
Kurzübersicht für HtrA Serine Peptidase 4 (HTRA4) (Middle Region) Peptid (ABIN978360)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-HTRA4 antibody (Catalog #: ARP55603_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
-
Hintergrund
-
HTRA4 is a member of the HtrA family of proteases. The protein contains a putative signal peptide, an insulin growth factor binding domain, a Kazal protease inhibitor domain, a conserved trypsin domain and a PDZ domain. Based on studies on other related family members, this enzyme may function as a secreted oligomeric chaperone protease to degrade misfolded secretory proteins. Other human HtrA proteins have been implicated in arthritis, tumor suppression, unfolded stress response, apoptosis, and aging.
Alias Symbols: FLJ90724
Protein Size: 476 -
Molekulargewicht
- 51 kDa
-
Gen-ID
- 203100
-
NCBI Accession
- NM_153692, NP_710159
-
UniProt
- P83105
Target
-